Affiliation:
1. Graduate School and Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, 3500-3 Minamitamagaki,
Suzuka 513-8670, Japan
Abstract
Abstract:
Type 2 diabetes mellitus (T2DM) is a risk factor for Alzheimer's Disease (AD). However,
the detailed mechanism underlying T2DM-related AD remains unknown. In DM, many types
of advanced glycation end products (AGEs) are formed and accumulated. In our previous study,
we demonstrated that Glyceraldehyde (GA)-derived toxic Advanced Glycation End products (toxic
AGEs, TAGE) strongly showed cytotoxicity against neurons and induced similar alterations to
those observed in AD. Further, GA induced dysfunctional neurite outgrowth via TAGE-β-tubulin
aggregation, which resulted in the TAGE-dependent abnormal aggregation of β-tubulin and tau
phosphorylation. Herein, we provide a perspective on the possibility that T2DM increases the
probability of AD onset and accelerates its progression.
Publisher
Bentham Science Publishers Ltd.